Subscribe to RSS
DOI: 10.1055/s-2006-941577
One-Pot Synthesis of Dinucleoside (3′,5′)-Methylphosphonothioates and their Seleno Congeners via the Phosphonotriazolidite Approach
Publication History
Publication Date:
22 May 2006 (online)
![](https://www.thieme-connect.de/media/synlett/200609/lookinside/thumbnails/10.1055-s-2006-941577-1.jpg)
Abstract
An efficient method for large laboratory scale synthesis of dinucleoside (3′,5′)-methylphosphonothioates and their methylphosphonoselenoate congeners is presented. Bis-(1,2,4-triazoloyl)methylphosphonite generated in situ from methyldichlorophosphine is used as a phosphitylating agent and the preparations are performed as one-pot-reactions without isolation of the reactive PIII intermediates.
Key words
oligonucleotides - dinucleoside - phosphonoselenoate
- 2
Eckstein F. Antisense Nucleic Acids Drug Dev. 2000, 10: 117 - 3
Reynolds MA.Hogrefe RI.Jaeger JA.Schwartz DA.Riley TA.Marvin WBW.Daily J.Vaghefi MM.Beck TA.Knowles SK.Klem RE.Arnold LJ. Nucleic Acids Res. 1996, 24: 4584 -
4a
Tian L.Claeboe CD.Hecht SM.Shuman S. Structure 2002, 12: 31 -
4b
Kurpiewski MR.Engler LE.Wozniak LA.Kobylanska A.Koziolkiewicz M.Stec WJ.Jen-Jacobson L. Structure 2004, 12: 1775 -
5a
Strauss JK.Maher LJ. Science 1994, 266: 1829 -
5b
Liu J.Declair AC.McKinney SA.Ha T.Norman DG.Lilley DMJ. Chem. Biol. 2005, 12: 217 - 6
Wilds CJ.Pattanayek R.Pan C.Wawrzak Z.Egli M. J. Am. Chem. Soc. 2002, 124: 14910 -
7a
Jaworska-Maslanka M.Kacperczyk W.Korczynski D.Lesnikowski ZJ. Antisense Nucleic Acids Drug Dev. 1997, 7: 23 -
7b
Lesnikowski ZJ.Jaworska M.Stec WJ. Nucleic Acids Res. 1990, 18: 2109 -
7c
Löschner T.Engels JW. Tetrahedron Lett. 1989, 30: 5587 -
7d
Miller PS.Dreon N.Pulford SM.McParland KB. J. Biol. Chem. 1980, 255: 9659 -
7e
Pyzowski J.Wozniak LA.Stec WJ. Org. Lett. 2000, 2: 771 -
7f
Wozniak LA.Pyzowski J.Stec WJ. J. Org. Chem. 1996, 61: 879 -
7g
Wozniak LA.Wieczorek M.Pyzowski J.Majzner W.Stec WJ. J. Org. Chem. 1998, 63: 5395 -
7h
Wozniak LA.Chworoś A.Pyzowski J.Stec WJ. J. Org. Chem. 1998, 63: 9109 -
7i
Wozniak LA. Rev. Heteroat. Chem. 1999, 19: 173 - 8
Schweitzer M.Engels JW. J. Biomol. Struct. Dyn. 1999, 16: 1177 - 9 Current Protocols in Nucleic Acid Chemistry, Beaucage S. L., Bergstrom D. E., Glid G. D., Jones R. A. John Wiley and Sons, Inc.; New York: 2000. ; and references cited therein
- 10
Wozniak LA.Pyzowski J.Wieczorek M.Stec WJ. J. Org. Chem. 1994, 59: 5843 - 11
Fourrey JL.Shire DJ. Tetrahedron Lett. 1981, 22: 729 - 12
Davis AM.Hall AD.Williams A. J. Am. Chem. Soc. 1988, 100: 5105 -
13a
El-Abadla N.Lampilas M.Hennig L.Findeisen M.Welzel P.Müller D.Markus A.van Heijenoort J. Tetrahedron 1999, 55: 699 -
13b
Heuer M.Hohgardt K.Heinemann F.Kühne H.Dietrich W.Grzelak D.Müller D.Welzel P.Markus A.van Heijenoort Y.van Heijenoort J. Tetrahedron 1994, 50: 2029 -
14a
Brill WK.-D.Yau EK.Caruthers MH. Tetrahedron Lett. 1988, 30: 6621 -
14b
Blackburn GM.Guo MJ. Tetrahedron Lett. 1993, 34: 149 - 15
Porrit GM.Reese CB. Tetrahedron Lett. 1990, 31: 1319 - 16
Fourey JL.Varenne J. Tetrahedron Lett. 1985, 26: 2663 - 19
Loschner T.Engels J. Tetrahedron Lett. 1989, 30: 5587 - 20
Wozniak LA.Majzner W.Stec WJ. Arkivoc 2004, (iii): 101 - 21
Wozniak LA.Bukowiecka-Matusiak M.Janicka M. Eur. J. Org. Chem. 2005, 5189 - 23
Wozniak LA.Stec WJ. In Frontiers in Nucleic AcidsSchinazi RF.Lotta DC. Informed Horizons, LLC; Tucker USA: 2004. p.457 - 24
Wozniak LA.Stec WJ. Tetrahedron Lett. 1999, 40: 2637
References and Notes
Current address: L. A. Wozniak, Medical University of Lodz, Chair of Endocrinology and Metabolic Diseases, Department of Structural Biology, 90-752 Lodz, 7/9 Zeligowskiego, Poland.
17The reactions of 2′-OMe ribonucleosides, not reported here in detail, required prolonged reaction times (first step: 1.5, second step usually about 2-2.5 h).
18General Procedure for Synthesis of Dinucleoside (3′,5′)-Methylphosphonothioates 2 or Dinucleoside (3′,5′)-Methylphosphonoselenoates 3 (1-mmol Scale). A solution of 1,2,4-triazole (0.346 g, 5 equiv) and Et3N (0.56 mL, 4 equiv) in dry THF (5 mL) was cooled in an ice bath and MePCl2 (0.094 mL, 1.1 equiv) was added with vigorous stirring. After 30 min a solution of 5′-O-DMT-(N-protected)-nucleoside 8 (1 equiv) in THF (5 mL) was added dropwise at 0 °C. Stirring was continued for 30 min, followed by addition of the 3′-O-protected nucleoside 11 (1.2 equiv) in THF (5 mL). The reaction mixture was warmed up to r.t., stirred for additional 1.5 h, and sulfur or selenium (2-3 fold excess) was added to this reaction mixture in one portion. Stirring was continued overnight, solvent was reduced to 1/3 volume, the oily residue was dissolved with CHCl3 (25 mL), and washed twice with NaHCO3 (0.1 M, 20 mL) and H2O. The organic layer was dried with MgSO4, concentrated to dryness and coevaporated twice with toluene. The residue was dissolved in small volume of dry THF (5 mL) and treated with Et3N·3HF-Et3N (3:1). After deprotection was complete (3-4 h), the reaction mixture was diluted with CHCl3, washed twice with NaHCO3 (0.1 M), concentrated, and subjected to a silica gel column chromatography (gradient 0-4% EtOH in CHCl3, and addition of 0.05% of Et3N). The collected fractions of diastereomers were concentrated and precipitated with hexane or PE and stored as white powders. Any excess of nucleoside 11 used in coupling reactions was recovered from column as 5′,3′-OH compound (after desilylation) and was subjected to 3′-O-protection (recycling).
22Fast-(S
p)-12: 31P NMR (202.46 MHz, CDCl3): δ = 100.1. 1H NMR (500 MHz, CDCl3): δ = 1.59 [t, J = 7.59 Hz, 6 H, CH(CH
3)], 1.94 (d, J = 15.61 Hz, 3 H, P-CH3), 2.10 [dq, 1 H, CH(CH3)], 2.56 [m, 1 H, CH(CH3)2], 3.44 [dd, 1 H, CH(CH3)], 3.6 [s, 3 H, (C)CH3O-C2′], 3.74 [s, 3 H, (U)CH3O-C2′], 3.80 [s, 6 H, (U)CH3O-DMT], 3.92 (m, 1 H, H5′), 4.18 [dd, J = 4.2, 2.1 Hz, 1 H, (C)H4′], 4.26 [d, J = 6.56 Hz, 1 H, (U)H2′], 5.36 [m, 1 H, (C)H2′], 5.87 [s, 1 H, (C)H1′], 6.05 [d, J = 3.41 Hz, 1 H, (U)H1′]. MS-FAB-
[M - H]: m/z calcd: 964.3; found: 962.6.
Slow-(R
p)-12: 31P NMR (CDCl3): δ = 98.26. 1H NMR (CDCl3): δ = 1.59 [t, J = 7.59 Hz, 6 H, CH(CH
3)2], 1.76 (d, J = 15.32 Hz, 3 H, P-CH3), 2.10 [dq, 1 H, CH(CH3)2], 2.56 [m, 1 H, CH(CH3)2], 3.44 [dd, 1 H, CH(CH3)], 3.55 [s, 3 H, (C)CH3O-C2′], 3.74 [s, 3 H, (U)CH3O-C2′], 3.81 [s, 6 H, (U)CH3O-DMT], 3.92 [m, 1 H, (C)H2′], 4.18 [dd, J = 4.2, 2.1 Hz, 1 H, (C)H4′], 4.26 [d, J = 6.56 Hz, 1 H, (U)H2′], 5.36 [m, 1 H, (C)H2′], 5.95 [s, 1 H, (C)H1′], 6.02 (d, J = 3.43 Hz, 1 H, (U)H1′], 7.42 [d, J = 7.40 Hz, 1 H, (C)5H], 7.92 [d, J = 8.20 Hz, 1 H, (U)6H], 8.16 [d, J = 7.50 Hz, 1 H, (C)6H], MS-FAB- [M - H]: m/z calcd: 964.3; found: 962.4.